Nasopharyngeal and Hypopharyngeal Carcinoma
1 clinical trials · Condition
◉ Watch Nasopharyngeal and Hypopharyngeal Carcinoma
| Record | Firm | Date |
|---|---|---|
| Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma (NCT05595265) | Sohag University | 2022-11-01 |
Track Nasopharyngeal and Hypopharyngeal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.